1995. Duration of letermovir primary prophylaxis in hematopoietic cell transplant recipients at high risk for cytomegalovirus infections and impact on outcomes

BACKGROUND: The incidence of clinically significant cytomegalovirus infection (CS-CMVi) in high risk allo-HCT recipients who are CMV seropositive (R+) has decreased in the era of letermovir (LTV) primary prophylaxis (PP) which is also associated with a reduction in all-cause mortality (ACM) and non-...

Descripción completa

Detalles Bibliográficos
Autores principales: Febres-Aldana, Anthony J, Khawaja, Fareed, Spallone, Amy, Srinivasan, Krithika, Lynn Shigle, Terri, Morado Aramburo, Oscar, Rondon, Gabriella, Ramdial, Jeremy, Shpall, Elizabeth, Ariza Heredia, Ella, Chemaly, Roy F, Sassine, Joseph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678504/
http://dx.doi.org/10.1093/ofid/ofad500.122

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678504/
http://dx.doi.org/10.1093/ofid/ofad500.122

Ejemplares similares